Skip to content

A narrative exploration of psilocybin’s potential in mental health

Jisu Park, Taejung Kim, Han-Tsung Min, Soon-Young Park, S. Na, H. Lee, Jaap Ham, Yejin Park

Frontiers in Psychiatry October 30, 2024 DOI: 10.3389/fpsyt.2024.1429373 via OpenAlex

Summary

AI-generated from the abstract

Psilocybin, a psychoactive substance, shows high therapeutic potential in psychiatry. This review examines its chemical properties, mechanisms of action, and clinical applications for treating mental health disorders, supported by accumulating evidence. Clinical trials indicate psilocybin is safe with manageable side effects, but additional safety measures such as dosing protocols, patient monitoring, and distress management strategies are needed. The work aims to deepen understanding of psilocybin's clinical impact and proposes future research directions for its integration into mainstream psychiatric treatments.

Study at a glance

Characteristics Review Peer reviewed
Topics Psilocybin
Keywords Psychiatry Hallucinogen Psychology Mental health
Citations 4
Key finding Psilocybin is safe in clinical trials with manageable side effects, but additional safety measures are required.

Abstract

Psilocybin, a psychoactive substance, has recently garnered attention for its high therapeutic potential in psychiatry. In this study, we investigated the multifaceted aspects of psilocybin, highlighting its chemical properties, mechanisms of action, and burgeoning role in psychiatric treatment. Furthermore, we examined the clinical applications and potential therapeutic benefits of psilocybin in the treatment of various mental health disorders, supported by accumulating clinical evidence. This review aims to deepen our understanding of the clinical impact of psilocybin, elucidate its therapeutic value, and propose directions for future research, thereby paving the way for its integration into mainstream psychiatric treatments. Psilocybin has been shown to be safe in clinical trials with manageable side effects. However, additional safety measures are required after this discussion, including dosing protocols, patient monitoring, and distress management strategies.

Explore topics

Comments

No comments yet.

Log in to comment